Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Prophylactic use of acid suppressants in adult acutely ill hospitalised patients: a systematic review with meta-analysis and trial sequential analysis

Publikation: Bidrag til tidsskriftReviewForskningpeer review

DOI

  1. Long-term Survival and Cognitive Function According to Blood Pressure Management During Cardiac Surgery. A Follow-up

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. The PANSAID Randomized Clinical Trial: A pre-planned 1-year follow-up regarding harm

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Maintaining Competence in Airway Management

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. The handling oxygenation targets in the intensive care unit (HOT-ICU) trial: Detailed statistical analysis plan

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. The PANSAID Randomized Clinical Trial: A pre-planned 1-year follow-up regarding harm

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Dr. Uhre et al. Reply

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Response

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. The handling oxygenation targets in the intensive care unit (HOT-ICU) trial: Detailed statistical analysis plan

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Vis graf over relationer

BACKGROUND: Acutely ill patients are at risk of stress-related gastrointestinal (GI) bleeding and prophylactic acid suppressants are frequently used. In this systematic review, we assessed the effects of stress ulcer prophylaxis (SUP) with proton pump inhibitors (PPIs) or histamine-2 receptor antagonists (H2RAs) versus placebo or no prophylaxis in acutely ill hospitalised patients.

METHODS: We conducted the review according to the PRISMA statement, the Cochrane Handbook and GRADE, using conventional meta-analysis and trial sequential analysis (TSA). The primary outcomes were all-cause mortality, clinically important GI bleeding and serious adverse events (SAEs). The primary analyses included overall low risk of bias trials.

RESULTS: We included 65 comparisons from 62 trials (n = 9713); 43 comparisons were from intensive care units. Only three trials (n = 3596) had overall low risk of bias. We did not find an effect on all-cause mortality (RR 1.03, 95% CI 0.94 to 1.14; TSA-adjusted CI 0.90 to 1.18; high certainty). The rate of clinically important GI bleeding was lower with SUP (RR 0.62, 95% CI 0.43 to 0.89; TSA-adjusted CI 0.14 to 2.81; moderate certainty). We did not find a difference in pneumonia rates (moderate certainty). Effects on SAEs, Clostridium difficile enteritis, myocardial ischaemia and health-related quality of life (HRQoL) were inconclusive due to sparse data. Analyses of all trials regardless of risk of bias were consistent with the primary analyses.

CONCLUSIONS: We did not observe a difference in all-cause mortality or pneumonia with SUP. The incidence of clinically important GI bleeding was reduced with SUP, whereas any effects on SAEs, myocardial ischaemia, Clostridium difficile enteritis and HRQoL were inconclusive.

STUDY REGISTRATION: PROSPERO registration number CRD42017055676; published study protocol: Marker, et al 2017 in Systematic Reviews.

OriginalsprogEngelsk
TidsskriftActa Anaesthesiologica Scandinavica
Vol/bind64
Udgave nummer6
Sider (fra-til)714-728
Antal sider15
ISSN0001-5172
DOI
StatusUdgivet - jul. 2020

ID: 59361920